Free Trial
OTCMKTS:DSRLF

DiaSorin (DSRLF) Stock Price, News & Analysis

DiaSorin logo
$109.60 0.00 (0.00%)
As of 03/28/2025

About DiaSorin Stock (OTCMKTS:DSRLF)

Key Stats

Today's Range
$109.60
$109.60
50-Day Range
$100.26
$109.60
52-Week Range
$100.26
$109.60
Volume
N/A
Average Volume
107 shs
Market Capitalization
$6.00 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.

Remove Ads
Receive DSRLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DiaSorin and its competitors with MarketBeat's FREE daily newsletter.

DSRLF Stock News Headlines

DiaSorin S.p.A. (0GZX) Receives a Hold from Barclays
DiaSorin S.p.A. (0GZX) Receives a Sell from Kepler Capital
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
DiaSorin stock rises despite mixed financial results
UBS Remains a Hold on DiaSorin S.p.A. (0GZX)
Kepler Capital Sticks to Its Sell Rating for DiaSorin S.p.A. (0GZX)
See More Headlines

DSRLF Stock Analysis - Frequently Asked Questions

DiaSorin's stock was trading at $106.8545 at the beginning of 2025. Since then, DSRLF shares have increased by 2.6% and is now trading at $109.60.
View the best growth stocks for 2025 here
.

Shares of DSRLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
3/30/2025
Next Earnings (Estimated)
5/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Private households
Sub-Industry
Misc.
Current Symbol
OTCMKTS:DSRLF
CIK
N/A
Fax
N/A
Employees
3,186
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.24 billion
Cash Flow
$9.71 per share
Price / Cash Flow
11.29
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$6.00 billion
Optionable
Not Optionable
Beta
0.24
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (OTCMKTS:DSRLF) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners